4//SEC Filing
Hunt Hazel 4
Accession 0000899243-22-032305
CIK 0001088856other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:30 PM ET
Size
8.8 KB
Accession
0000899243-22-032305
Insider Transaction Report
Form 4
Hunt Hazel
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2022-09-28$2.08/sh+50,000$104,000→ 103,143 total - Tax Payment
Common Stock
2022-09-28$26.04/sh−29,997$781,122→ 73,146 total - Exercise/Conversion
Stock option (right to buy)
2022-09-28−50,000→ 0 totalExercise: $2.08Exp: 2023-01-30→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on January 30, 2023.
- [F2]Fully exercisable.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001698307
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 4:30 PM ET
- Size
- 8.8 KB